SCHEMBL366237

SCHEMBL366237

CCc1ccc(OCc2ccc(C(=O)NS(C)(=O)=O)cc2OC)cc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 1/20 0.51
SCN9A Q15858 11/20 0.50
PTGER4 P35408 1/20 0.50
SCN5A Q14524 1/20 0.47
RORC P51449 1/20 0.47
MEN1 O00255 1/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
KMT2A Q03164 1/20 0.47
RXRA P19793 1/20 0.45
RXRB P28702 1/20 0.45
PTPN2 P17706 1/20 0.44
PTPN1 P18031 1/20 0.44
PTPN7 P35236 1/20 0.44
SMPD1 P17405 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diethylamine SCHEMBL16239822 0.96 HDAC8 (0.48) HDAC8SCN9APTGER4SCN5ARORC
SCHEMBL366136 0.85 SCN9A (0.49) HDAC8SCN9APTGER4SCN5ARXRA
SCHEMBL16239703 0.83 SCN9A (0.67) HDAC8SCN9ASCN5A
SCHEMBL364340 0.82 RXRA (0.62) SCN9AMEN1ALDH1A1KMT2ARXRA
Diethylamine SCHEMBL16239787 0.82 SCN9A (0.46) SCN9APTGER4SCN5ARXRARXRB
SCHEMBL365920 0.80 RORC (0.62) SCN9APTGER4RORCMEN1ALDH1A1
SCHEMBL366513 0.80 PTGER4 (0.47) SCN9APTGER4SCN5AMEN1ALDH1A1
Diethylamine SCHEMBL16239678 0.78 RXRA (0.57) SCN9AMEN1ALDH1A1KMT2ARXRA
SCHEMBL14890546 0.77 ALDH1A1 (0.54) SCN9APTGER4RORCMEN1ALDH1A1
SCHEMBL16239768 0.77 ALDH1A1 (0.70) SCN9APTGER4ALDH1A1SMPD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096500-B2 Acyl sulfonamide compounds PFIZER LIMITED (GB) 2015-08-04 US disclosed
EP-2593428-A2 N-SULFONYLBENZAMIDES AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS Pfizer Limited (GB) 2013-05-22 EP disclosed
US-20130109701-A1 Chemical Compounds PFIZER LIMITED (GB) 2013-05-02 US disclosed
WO-2012007868-A2 CHEMICAL COMPOUNDS PFIZER LIMITED (GB) 2012-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130109701-A1 Chemical Compounds SCN1A, SCN1B, SCN7A HDAC8 925/4885SCN9A 16/4885PTGER4 1876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.